Search research articles
Contact Us
Filters
Showing results (211-220 of 527) with videos related to
Page
of 53
Sort By:
Neurosurgical Focus
|
June 2, 2018
5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients
Barbara Kiesel, Matthias Millesi, Adelheid Woehrer, et al.
European Journal of Haematology
|
December 30, 2014
Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review
Marija Bojic, Anna S Berghoff, Marlene Troch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Matthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Journal of Cellular and Molecular Medicine
|
April 13, 2024
The plasma miRNome and venous thromboembolism in high-grade glioma: miRNA Sequencing of a nested case-control cohort
Friedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Neuro-Oncology Practice
|
March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?
Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
World Neurosurgery
|
July 23, 2016
Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases
Josa M Frischer, Astrid Fraller, Ammar Mallouhi, et al.
Neuro-Oncology Advances
|
August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
Katharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2017
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer
Emilie Le Rhun, Nicolas Bertrand, Aurélie Dumont, et al.
Clinical Nuclear Medicine
|
November 19, 2020
Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI
Angelika M Starzer, Anna S Berghoff, Tatjana Traub-Weidinger, et al.
Neuro-Oncology
|
August 2, 2019
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial
Julia Furtner, Els Genbrugge, Thierry Gorlia, et al.
Page
of 53
Search research articles
Search
Showing results (211-220 of 527) with videos related to
Sort By:
Page
of 53
Neurosurgical Focus
|
June 2, 2018
5-ALA-induced fluorescence as a marker for diagnostic tissue in stereotactic biopsies of intracranial lymphomas: experience in 41 patients
Barbara Kiesel, Matthias Millesi, Adelheid Woehrer, et al.
European Journal of Haematology
|
December 30, 2014
Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review
Marija Bojic, Anna S Berghoff, Marlene Troch, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]
|
February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity
Matthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Journal of Cellular and Molecular Medicine
|
April 13, 2024
The plasma miRNome and venous thromboembolism in high-grade glioma: miRNA Sequencing of a nested case-control cohort
Friedrich Erhart, Georg Widhalm, Barbara Kiesel, et al.
Neuro-Oncology Practice
|
March 20, 2025
Temozolomide chemotherapy for patients with newly diagnosed glioblastoma in the CENTRIC EORTC 26071-22072 and CORE trials: Does time of administration matter?
Marjolein Geurts, Luzia Berchtold, Franz Koenig, et al.
World Neurosurgery
|
July 23, 2016
Evaluation of Dose-Staged Gamma Knife Radiosurgical Treatment Method for High-Risk Brain Metastases
Josa M Frischer, Astrid Fraller, Ammar Mallouhi, et al.
Neuro-Oncology Advances
|
August 11, 2022
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma
Katharina Seystahl, Felix Boakye Oppong, Emilie Le Rhun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 7, 2017
Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer
Emilie Le Rhun, Nicolas Bertrand, Aurélie Dumont, et al.
Clinical Nuclear Medicine
|
November 19, 2020
Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET/MRI
Angelika M Starzer, Anna S Berghoff, Tatjana Traub-Weidinger, et al.
Neuro-Oncology
|
August 2, 2019
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial
Julia Furtner, Els Genbrugge, Thierry Gorlia, et al.
Page
of 53